Is Fractyl Health Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: GUTS) stock is to Strong Buy GUTS stock.
Out of 1 analyst, 1 (100%) are recommending GUTS as a Strong Buy, 0 (0%) are recommending GUTS as a Buy, 0 (0%) are recommending GUTS as a Hold, 0 (0%) are recommending GUTS as a Sell, and 0 (0%) are recommending GUTS as a Strong Sell.
What is GUTS's revenue growth forecast for 2026-2026?
(NASDAQ: GUTS) Fractyl Health's forecast annual revenue growth rate of 1,336.08% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 61.06%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.11%.
Fractyl Health's revenue in 2024 is $120,000.
In 2026, GUTS is forecast to generate $595,318,397 in revenue, with the lowest revenue forecast at $595,318,397 and the highest revenue forecast at $595,318,397.
What is GUTS's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: GUTS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.04%.
What is GUTS's Price Target?
According to 1 Wall Street analyst that have issued a 1 year GUTS price target, the average GUTS price target is $18.00, with the highest GUTS stock price forecast at $18.00 and the lowest GUTS stock price forecast at $18.00.
The Wall Street analyst predicted that Fractyl Health's share price could reach $18.00 by Feb 27, 2025. The average Fractyl Health stock price prediction forecasts a potential upside of 168.66% from the current GUTS share price of $6.70.
What is GUTS's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: GUTS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.